selected publications
-
academic article
- A capsaicinoid-based soft drug, AG1529, for attenuating TRPV1-mediated histaminergic and inflammatory sensory neuron excitability. SCIENTIFIC REPORTS. 1-18. 2020
- Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 1-20. 2019
- Effect of a novel TRPV1 antagonist on capsaicin nociceptors. FRONTIERS IN CELLULAR NEUROSCIENCE. 1-4. 2018
- Targeting transient receptor potential vanilloid 1 channel (TRPV1) softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders. JOURNAL OF MEDICINAL CHEMISTRY. 4436-4455. 2018
-
congress communication
- Evaluación de los mecanismos moleculares que se establecen durante una crisis de migraña a nivel de SNP 2020
- Evaluación de los mecanismos moleculares que se establecen durante una crisis de migraña a nivel de SNP 2020
- In vitro characterization of a TRPV1 soft antagonist. 2019
- In vitro characterization of a TRPV1 soft antagonist. 2019
- A capsaicin-based TRPV1 soft antagonist as an anti-pruritic drug candidate 2019
- In vitro characterization of a TRPV1 soft antagonist. 2019
- Targeting TRPV1 softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders 2018